Annual General Meeting in Getinge AB

Getinge, 15 March 2010

Annual General Meeting in Getinge AB

The shareholders of Getinge AB (publ) are invited to attend the Annual General
Meeting to be held on Wednesday 21 April 2010 at 4.00 p.m., in Kongresshallen,
Hotel Tylösand, Halmstad.

As stated in the notice to convene the Annual General Meeting the following
matters, among others, are proposed:

A dividend of SEK 2.75 per share is proposed.

Cecilia Daun Wennborg is proposed as new member of the Board.

Re-election is proposed to take place of the Board members Carl Bennet, Johan
Bygge, Rolf Ekedahl, Carola Lemne, Johan Malmquist and Johan Stern. As Chairman
of the Board, Carl Bennet is proposed to be re-elected. Margareta Norell
Bergendahl has declined re-election.

Cecilia Daun Wennborg, age 45 and Bachelor of Economics, is, up to and including
March 2010, Vice President of Ambea AB. She is also Board member of Hakon Invest
AB and Vårdföretagarna. Cecilia Daun Wennborg has previously been CEO of Carema
Vård och Omsorg AB, CFO of Ambea AB and Carema Vård och Omsorg AB, acting CEO of
Skandiabanken, head of the Swedish operations of Skandia and CEO of Skandia
Link.

The notice to attend the Annual General Meeting is attached in its entirety to
this press release.

Getinge, 15 March 2010
Getinge AB (publ)

For further information: 
Johan Malmquist, CEO
Ulf Grunander, CFO
+46 (0)35-15 55 00

GETINGE GROUP is a leading global provider of products and systems that
contribute to quality enhancement and cost efficiency within healthcare and life
sciences. We operate under the three brands of ArjoHuntleigh, GETINGE and
MAQUET. ArjoHuntleigh focuses on patient mobility and wound management
solutions. GETINGE provides solutions for infection control within healthcare
and contamination prevention within life sciences. MAQUET specializes in
solutions, therapies and products for surgical interventions and intensive care.



This information is such that Getinge AB (publ) must disclose in accordance with
the Swedish Securities Market Act and/or the Financial Instruments Trading Act.
This information was submitted for publication on 15 March 2010, at 08:30 a.m.